UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM SD
______________________________
SPECIALIZED DISCLOSURE REPORT
______________________________
THERMO FISHER SCIENTIFIC INC.
(Exact name of registrant as specified in its charter)
______________________________
| | | | | | | | | | | |
| Delaware | | 1-8002 | |
(State or other jurisdiction of
incorporation or organization) | | (Commission
File Number) | |
| | | | | | | | |
168 Third Avenue
Waltham, MA | | 02451 |
| (Address of principal executive offices) | | (Zip Code) |
Michael A. Boxer (781) 622-1000
(Name and telephone number, including area code, of the person to contact in connection with this report)
________________________________
Check the appropriate box to indicate the rule pursuant to which this form is being filed:
ý Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2021.
Introduction
This Form SD for Thermo Fisher Scientific Inc. (“Thermo Fisher,” the “Company,” “we,” or “our”) is provided in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (“Rule 13p-1”) for the reporting period from January 1, 2021 to December 31, 2021.
In accordance with this regulation, we designed and executed a supply chain due diligence process in accordance with Annex I of the Organisation for Economic Co-operation and Development’s (“OECD”) Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas (“OECD Guidance”) as outlined in this Form SD and detailed in the accompanying Conflict Minerals Report.
Company Overview
Thermo Fisher is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. We serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. In line with this Mission, we are committed to the responsible sourcing of materials used in our products, and we strive to interact with partners who share these values.
Section 1 – Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Our overall process for conflict minerals included steps such as enhancing our conflict minerals program, setting forth our expectations on this topic for our supply base in a conflict minerals statement, designing and executing a reasonable country of origin inquiry, and performing certain supply chain due diligence.
Conflict Minerals Program
In response to the SEC’s Conflict Minerals Rule, we assembled a conflict minerals project team, which is led by a dedicated project manager. We continue to build upon our strong foundation within and outside of our organization and, with our supply chain partners, to strive for a transparent and responsible supply chain to support conflict minerals reporting in future years. Our company’s conflict minerals statement is available in the “global supply chain” section on our public website located at:
https://corporate.thermofisher.com/us/en/index/corporate-social-responsibility/operations/global-supply-chain.html
Published Results
A copy of our Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, and may be found on our public website at:
https://corporate.thermofisher.com/us/en/index/corporate-social-responsibility/operations/global-supply-chain.html
Item 1.02 Exhibit
Based on our Reasonable Country of Origin inquiry, and subsequent due diligence, we are filing as an exhibit to this Form SD the Conflict Minerals Report required by Item 1.01.
Section 3 – Exhibits
Item 3.01 Exhibits
Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | | | | |
| Date: May 27, 2022 | By: | | /s/ Michael A. Boxer |
| Name: | | Michael A. Boxer |
| Title: | | Senior Vice President, General Counsel and Secretary |
